Delivery Order SPE2DB20D1100-SPE2DB24FC6X3

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,185.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 23, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $30,356.25 firm-fixed price delivery order is for the supply of Concerta ER 18 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The award falls under a broader Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,693.32 Firm Fixed Price Delivery Order contract is for the supply of 100 tablets of Concerta ER 18 mg, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through February 24, 2025. This award is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,281.02 firm fixed-price delivery order is for the supply of 100 units of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, valued at $22,995.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36mg Concerta ER Tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,407.86 firm fixed-price delivery order is for Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $15,539.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Concerta ER 27 mg tablets, a medication used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 2, 2024. The $62,202.74 firm fixed-price delivery order is for the supply of Concerta ER 18 mg tablets, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $12,578.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Concerta ER 36 mg tablets, a medication commonly used to treat attention deficit hyperactivity disorder (ADHD). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,883.88, is a delivery order under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is a $999,999,999 IDC running through November 2026. The contract is for the delivery of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract does not have a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC6X3
    Delivery Order

This federal contract award SPE2DB20D1100|SPE2DB24FC6X3, valued at $13,973.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the provision of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This award is a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition. The contract is a firm fixed-price arrangement, with a performance period that will conclude on July 12, 2024.

Generated 5/17/25, 10:00 AM